Survey on Chinese urologists of BCG utilization in Chinese NMIBC patients

10/05/2022
07/07/2022
EU PAS number:
EUPAS47111
Study
Planned
Study type

Study type

Non-interventional study

Scope of the study

Disease epidemiology
Drug utilisation
Non-interventional study

Non-interventional study design

Cross-sectional
Population studied

Age groups

  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)

Estimated number of subjects

322
Study design details

Main study objective

• To describe characteristics of Chinese NMIBC patients • To describe BCG utilization pattern in China in NMIBC treatment • To learn about factors which could impact physicians' prescribing decision and patients' choice of BCG treatment

Outcomes

1.Chinese NMIBC patients’ characteristics 2.Current BCG treatment patterns and the most common one in Chinese high risk NMIBC patients’ treatment 3.Factors may impact clinical decisions(income of the family, disease stage, complicated operation, treatment frequency etc. )in Chinese high risk NMIBC patients’ treatment 4.Reasons of BCG discontinued other than disease progression

Data analysis plan

Data will be analyzed descriptively: number, rate, mean, median according to the intervention practiced and in the overall population studied.